This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1982;19(3):387-415.

doi: 10.1016/0163-7258(82)90074-2.

Antiviral effects of phosphonoformate (PFA, foscarnet sodium)

B Oberg

PMID: 6201932
DOI: 10.1016/0163-7258(82)90074-2

Review

Antiviral effects of phosphonoformate (PFA, foscarnet sodium)

B Oberg. Pharmacol Ther. 1982.

. 1982;19(3):387-415.

doi: 10.1016/0163-7258(82)90074-2.

Author

B Oberg

PMID: 6201932
DOI: 10.1016/0163-7258(82)90074-2

No abstract available

PubMed Disclaimer

Similar articles

Antiviral effects of phosphonoformate (PFA, foscarnet sodium).
Oberg B. Oberg B. Pharmacol Ther. 1989;40(2):213-85. doi: 10.1016/0163-7258(89)90097-1. Pharmacol Ther. 1989. PMID: 2543994 Review.
The antiherpesvirus action of phosphonoacetate.
Boezi JA. Boezi JA. Pharmacol Ther. 1979;4(1):231-43. doi: 10.1016/0163-7258(79)90021-4. Pharmacol Ther. 1979. PMID: 88744 Review. No abstract available.
Inhibition of HTLV-III/LAV replication by foscarnet.
Sarin PS, Taguchi Y, Sun D, Thornton A, Gallo RC, Oberg B. Sarin PS, et al. Biochem Pharmacol. 1985 Nov 15;34(22):4075-9. doi: 10.1016/0006-2952(85)90392-2. Biochem Pharmacol. 1985. PMID: 2415134 No abstract available.
Trisodium phosphonoformate, a new antiviral compound.
Helgstrand E, Eriksson B, Johansson NG, Lannerö B, Larsson A, Misiorny A, Norén JO, Sjöberg B, Stenberg K, Stening G, Stridh S, Oberg B. Helgstrand E, et al. Science. 1978 Sep 1;201(4358):819-21. doi: 10.1126/science.210500. Science. 1978. PMID: 210500
Mechanism of action of foscarnet against viral polymerases.
Crumpacker CS. Crumpacker CS. Am J Med. 1992 Feb 14;92(2A):3S-7S. doi: 10.1016/0002-9343(92)90329-a. Am J Med. 1992. PMID: 1371038 Review.

See all similar articles

Cited by

PPi analogs as inhibitors of human T-lymphotropic virus type III reverse transcriptase.
Vrang L, Oberg B. Vrang L, et al. Antimicrob Agents Chemother. 1986 May;29(5):867-72. doi: 10.1128/AAC.29.5.867. Antimicrob Agents Chemother. 1986. PMID: 2425731 Free PMC article.
Effect of foscarnet cream on experimental UV radiation-induced herpes labialis.
Bernstein DI, Schleupner CJ, Evans TG, Blumberg DA, Bryson Y, Grafford K, Broberg P, Martin-Munley S, Spruance SL. Bernstein DI, et al. Antimicrob Agents Chemother. 1997 Sep;41(9):1961-4. doi: 10.1128/AAC.41.9.1961. Antimicrob Agents Chemother. 1997. PMID: 9303394 Free PMC article. Clinical Trial.
Cytomegalovirus colitis and oesophageal ulceration in the context of AIDS: clinical manifestations and preliminary report of treatment with Foscarnet (phosphonoformate).
Weber JN, Thom S, Barrison I, Unwin R, Forster S, Jeffries DJ, Boylston A, Pinching AJ. Weber JN, et al. Gut. 1987 Apr;28(4):482-7. doi: 10.1136/gut.28.4.482. Gut. 1987. PMID: 3034745 Free PMC article. Clinical Trial.
The future of antiviral chemotherapy.
Crowe S, Mills J. Crowe S, et al. Dermatol Clin. 1988 Oct;6(4):521-37. doi: 10.1016/S0733-8635(18)30631-4. Dermatol Clin. 1988. PMID: 3067915 Free PMC article. Review.
Treatment of CMV retinitis in an AIDS patient.
Acheson JF, Shah SM, Spalton DJ, Bradbeer C, Thin RN. Acheson JF, et al. Br J Ophthalmol. 1987 Nov;71(11):810-6. doi: 10.1136/bjo.71.11.810. Br J Ophthalmol. 1987. PMID: 2825756 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database